Suchergebnisse - "O'Day, Steven J"

PubPharm (17)

1

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States : An Expanded Access Program

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2017

von Gangadhar, T. | Hwu, W. | Postow, M. | +14

2

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2015

von Ribas, A. | Puzanov, I. | Dummer, R. | +33

CommentIn: Lancet Oncol. 2015 Aug;16(8):873-4. - PMID 26115798

3

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Carvajal, R. | Lawrence, D. | Weber, J. | +17

4

Clinical cancer advances 2015 : Annual report on progress against cancer from the American Society of Clinical Oncology

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Masters, G. | Krilov, L. | Bailey, H. | +16

5

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Hodi, F. | Corless, C. | Giobbie-Hurder, A. | +21

CommentIn: J Clin Oncol. 2013 Sep 10;31(26):3173-5. - PMID 23940226

6

Development of ipilimumab : a novel immunotherapeutic approach for the treatment of advanced melanoma

enthalten in: Annals of the New York Academy of Sciences | 2013

von Wolchok, J. | Hodi, F. | Weber, J. | +9

7

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2012

von O'Day, S. | Pavlick, A. | Albertini, M. | +7

8

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours : a phase 1 dose-escalation trial

enthalten in: Lancet (London, England) | 2012

von Falchook, G. | Long, G. | Kurzrock, R. | +14

CommentIn: Lancet. 2012 May 19;379(9829):1858-9. - PMID 22608322

9

Sunitinib therapy for melanoma patients with KIT mutations

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von Minor, D. | Kashani-Sabet, M. | Garrido, M. | +3

10

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases : retrospective analysis of data from a phase 2 trial

enthalten in: Melanoma research | 2011

von Weber, J. | Amin, A. | Minor, D. | +3